Immunoprecise Antibodies shares owned by Citadel Advisors
Quarter-by-quarter ownership of Immunoprecise Antibodies (IPA) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Immunoprecise Antibodies
Tip: Access up to 7 years of quarterly data
All positions including Immunoprecise Antibodies held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunoprecise Antibodies by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $517k | 302k | 1.71 |
| 2023-09-30 | $443k | 242k | 1.83 |
| 2023-06-30 | $819k | 277k | 2.96 |
| 2023-03-31 | $1.1M | 382k | 2.77 |
| 2022-12-31 | $1.7M | 328k | 5.30 |
| 2022-06-30 | $1.5M | 395k | 3.86 |
| 2022-03-31 | $1.6M | 319k | 5.16 |
| 2021-12-31 | $951k | 177k | 5.36 |
| 2021-09-30 | $1.1M | 174k | 6.22 |
| 2021-06-30 | $93k | 15k | 6.04 |